Skip to main content

Looking Ahead to the New Year

Return of Information

Over 20,000 participants have enrolled in Connect! We're excited to begin sharing group-level information about the participant cohort to date. Currently, we're exploring data from the first Connect survey, which includes information on sleep patterns and behaviors. You may read the Did You Know article on healthy sleep to see what we’ve learned so far about Connect participants who have answered their survey, the importance of sleep for cancer prevention, and tips for getting better sleep. We look forward to sharing more group-level information throughout the future as we continue to study the responses from the first survey. 

Your Samples are Key to Studying Cancer Prevention

Samples are like time capsules of information about your health. When we begin to study the samples you donated for Connect, we will share an updated timeline for when you may expect to see some early results. We'll collect similar samples and study them at different time points throughout the study to better understand how health changes over time. While some tests may be run earlier, it will be years before we run other tests on the samples. Saving some of the samples for tests that haven’t been developed yet may help us learn more about cancer prevention in the future. 

2024 Study Activities

The Connect research team has several activities that participants can expect in the upcoming year. In 2024, the PROMIS Survey (which measures physical, mental, and social well-being) and the Dietary History Questionnaire (which asks about diet and food/beverage intake) will be available to you on MyConnect. We will email you when these surveys are ready.  

We’re also looking forward to launching at home mouthwash collection for the study. The mouthwash sample can be collected by you in the comfort of your home and mailed back to the Connect lab. We will study the samples in the future to learn more about the causes of cancer. If you already donated your first blood, urine, and mouthwash samples for Connect at an appointment, thank you! If you recently donated just blood and urine at your health care system or clinic, keep an eye out for an email from us letting you know that your mouthwash home collection kit has shipped. The kit has instructions and everything you need to collect and send back your sample. We’ll start shipping kits in the new year.  

Update Your Information

Have you moved recently or need to update your address? Please help keep our research team up to date by updating your preferred address through MyConnect. Sharing your current address will allow our team to share important updates and other study communications through the mail. We also want to mail you a birthday card! 

A Note of Thanks

On behalf of the Connect Coordinating Center, thank you for your ongoing commitment to the study. Your contributions hold great value for the future of cancer prevention. I hope you feel supported by our team, and that you continue to spread the word about Connect within your community.  

Headshot of Connect Senior Scientist Mia Gaudet, Ph.D.

Mia Gaudet, Ph.D., leads the Connect for Cancer Prevention Study at NCI.

As always, stay tuned for emails from us, and please visit MyConnect to check for any surveys you might need to complete under the “To Do” tab of your dashboard. If you have any feedback or questions, contact our team at the Connect Support Center.

I look forward to keeping in touch throughout the new year. Wishing you a happy and healthy holiday season!  

Mia Gaudet, Ph.D.
Senior Scientist
Division of Cancer Epidemiology and Genetics
National Cancer Institute 

  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Looking Ahead to the New Year was originally published by the National Cancer Institute.”